STRATEC Biomedical AG 

19.01.2015 16:37

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

BNP Paribas Investment Partners S.A., Paris, France has notified us pursuant to sec. 21 para. 1 WpHG on 15 January 2015, that on 15 January 2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 3% and that the percentage of voting rights on that day amounted to 3.02% (356,478 voting rights).

Of these voting rights 3.02% (356,478 voting rights) are attributable to BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG.

Also, of these voting rights 2.95% (347,651 voting rights) are attributable to BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.



19.01.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---